Vicki L. Goodman - 24 Feb 2025 Form 4 Insider Report for Mural Oncology plc (MURA)

Signature
/s/ Maiken Keson-Brookes, attorney-in-fact for Vicki L. Goodman
Issuer symbol
MURA
Transactions as of
24 Feb 2025
Net transactions value
-$51,294
Form type
4
Filing time
25 Feb 2025, 16:03:08 UTC
Previous filing
08 Nov 2024
Next filing
05 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MURA Ordinary Shares Sale $51,294 -13,186 -19% $3.89 54,763 24 Feb 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares automatically sold by the Reporting Person pursuant to a Rule 10b5-1 trading arrangement that was entered into by the Reporting Person on October 24, 2024.
F2 Includes 54,763 unvested restricted stock units.